Compare Stocks: HCAT, MDRX, SOPH, and WEAV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HCAT Health Catalyst	$2.28 +3.2%	$1.93	$0.96 ▼ $3.88	$163.31M	1.55	639,739 shs	471,649 shs
MDRX Veradigm	$4.80	$4.91	$3.00 ▼ $6.00	$587.04M	0.53	134,396 shs	4,011 shs
SOPH SOPHiA GENETICS	$6.84 +20.2%	$5.52	$2.92 ▼ $6.98	$477.36M	0.96	292,137 shs	1.62 million shs
WEAV Weave Communications	$6.86 +1.6%	$6.21	$4.24 ▼ $8.11	$537.07M	1.67	1.05 million shs	722,910 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HCAT Health Catalyst	+5.74%	+2.79%	+6.25%	+38.13%	-37.22%
MDRX Veradigm	0.00%	-4.00%	-5.79%	-3.23%	-1.03%
SOPH SOPHiA GENETICS	+0.35%	+0.71%	+6.36%	+12.23%	+80.06%
WEAV Weave Communications	+3.26%	+1.41%	+2.90%	+10.66%	-1.53%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HCAT Health Catalyst	$2.28 +3.2%	$1.93	$0.96 ▼ $3.88	$163.31M	1.55	639,739 shs	471,649 shs
MDRX Veradigm	$4.80	$4.91	$3.00 ▼ $6.00	$587.04M	0.53	134,396 shs	4,011 shs
SOPH SOPHiA GENETICS	$6.84 +20.2%	$5.52	$2.92 ▼ $6.98	$477.36M	0.96	292,137 shs	1.62 million shs
WEAV Weave Communications	$6.86 +1.6%	$6.21	$4.24 ▼ $8.11	$537.07M	1.67	1.05 million shs	722,910 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HCAT Health Catalyst	+5.74%	+2.79%	+6.25%	+38.13%	-37.22%
MDRX Veradigm	0.00%	-4.00%	-5.79%	-3.23%	-1.03%
SOPH SOPHiA GENETICS	+0.35%	+0.71%	+6.36%	+12.23%	+80.06%
WEAV Weave Communications	+3.26%	+1.41%	+2.90%	+10.66%	-1.53%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HCAT Health Catalyst	2.23	Hold	$2.93	28.59% Upside
MDRX Veradigm	0.00	N/A	N/A	N/A
SOPH SOPHiA GENETICS	2.40	Hold	$9.00	31.58% Upside
WEAV Weave Communications	2.40	Hold	$8.33	21.49% Upside

Current Analyst Ratings Breakdown

Latest HCAT, MDRX, SOPH, and WEAV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/28/2026	HCAT Health Catalyst	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/23/2026	HCAT Health Catalyst	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
7/21/2026	HCAT Health Catalyst	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$2.00 ➝ $3.00
7/21/2026	SOPH SOPHiA GENETICS	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/20/2026	SOPH SOPHiA GENETICS	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$12.00
7/17/2026	SOPH SOPHiA GENETICS	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/8/2026	WEAV Weave Communications	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/26/2026	HCAT Health Catalyst	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$1.00 ➝ $1.75
6/24/2026	HCAT Health Catalyst	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/15/2026	SOPH SOPHiA GENETICS	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$8.00
5/12/2026	HCAT Health Catalyst	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$2.00 ➝ $1.75

(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HCAT Health Catalyst	$311.14M	0.54	$2.19 per share	1.04	$3.47 per share	0.66
MDRX Veradigm	$1.53B	0.38	N/A	N/A	N/A	∞
SOPH SOPHiA GENETICS	$77.27M	7.43	N/A	N/A	$0.69 per share	9.91
WEAV Weave Communications	$239.02M	2.28	$0.06 per share	106.61	$1.06 per share	6.47

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HCAT Health Catalyst	-$177.97M	-$3.72	N/A	N/A	N/A	-87.69%	-3.52%	-1.77%	8/6/2026 (Estimated)
MDRX Veradigm	N/A	N/A	23.25	N/A	N/A	N/A	N/A	N/A	N/A
SOPH SOPHiA GENETICS	-$79M	-$0.52	N/A	N/A	N/A	-44.48%	-62.74%	-21.85%	8/4/2026 (Estimated)
WEAV Weave Communications	-$28.05M	-$0.31	N/A	N/A	N/A	-10.05%	-26.46%	-10.39%	8/6/2026 (Confirmed)

Latest HCAT, MDRX, SOPH, and WEAV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	HCAT Health Catalyst	$0.02	N/A	N/A	N/A	$69.00 million	N/A
8/6/2026	Q2 2026	WEAV Weave Communications	$0.03	N/A	N/A	N/A	$67.88 million	N/A
8/4/2026	Q2 2026	SOPH SOPHiA GENETICS	-$0.21	-$0.30	-$0.09	-$0.30	$21.72 million	$23.31 million
5/11/2026	Q1 2026	HCAT Health Catalyst	$0.01	$0.02	+$0.01	-$1.53	$69.24 million	$70.76 million
5/5/2026	Q1 2026	SOPH SOPHiA GENETICS	-$0.2325	-$0.27	-$0.0375	-$0.27	$20.40 million	$21.69 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HCAT Health Catalyst	N/A	N/A	N/A	N/A	N/A
MDRX Veradigm	N/A	N/A	N/A	N/A	N/A
SOPH SOPHiA GENETICS	N/A	N/A	N/A	N/A	N/A
WEAV Weave Communications	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HCAT Health Catalyst	1.10	1.69	1.69
MDRX Veradigm	N/A	N/A	N/A
SOPH SOPHiA GENETICS	1.05	2.06	1.90
WEAV Weave Communications	0.08	1.24	1.24

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HCAT Health Catalyst	85.00%
MDRX Veradigm	N/A
SOPH SOPHiA GENETICS	31.59%
WEAV Weave Communications	86.83%

Insider Ownership

Company	Insider Ownership
HCAT Health Catalyst	19.40%
MDRX Veradigm	2.29%
SOPH SOPHiA GENETICS	4.88%
WEAV Weave Communications	16.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HCAT Health Catalyst	1,200	73.89 million	59.56 million	Optionable
MDRX Veradigm	8,000	122.30 million	105.18 million	No Data
SOPH SOPHiA GENETICS	520	83.89 million	79.80 million	Not Optionable
WEAV Weave Communications	890	79.57 million	66.52 million	Optionable

HCAT, MDRX, SOPH, and WEAV Headlines

Recent News About These Companies

Weave Communications (WEAV) Projected to Release Earnings on Thursday

July 30, 2026 | americanbankingnews.com

Weave Communications (WEAV) Projected to Announce Quarterly Earnings on Thursday

July 30, 2026 | marketbeat.com

Engine Capital Management LP Makes New $4.86 Million Investment in Weave Communications, Inc. $WEAV

July 28, 2026 | marketbeat.com

Pale Fire Capital SE Acquires Shares of 1,492,806 Weave Communications, Inc. $WEAV

July 25, 2026 | marketbeat.com

Weave Communications (NYSE:WEAV) & Money On Mobile (OTCMKTS:MOMT) Head-To-Head Contrast

July 25, 2026 | americanbankingnews.com

Weave Communications (NYSE:WEAV) Stock Price Down 4.8% - What's Next?

July 21, 2026 | marketbeat.com

Weave to Announce Second Quarter 2026 Financial Results on August 6, 2026

July 20, 2026 | businesswire.com

Weave Launches Authorized Integration with Elation Health, Significantly Reducing Manual Workflows for Primary Care Practices

July 18, 2026 | finance.yahoo.com

Weave Communications: Why Its Shift To Consumption Pricing Makes It A Buy Opportunity

July 13, 2026 | seekingalpha.com

369,969 Shares in Weave Communications, Inc. $WEAV Acquired by Y Intercept Hong Kong Ltd

July 10, 2026 | marketbeat.com

KILN TO ANCHOR HOSPITALITY-DRIVEN FLEXIBLE WORKSPACE AND COMMUNITY HUB IN THE WEAVE AT OCVIBE

June 15, 2026 | prnewswire.com

Weave Communications Stockholders Back Board and Auditor Choices

June 10, 2026 | tipranks.com

Weave Unveils Enterprise-Grade, Omnichannel AI Receptionist Built with Google Cloud’s Gemini Enterprise Agent Platform to Transform Healthcare Front Offices

May 28, 2026 | lasvegassun.comL

How The Weave Communications (WEAV) Story Is Shifting With New Guidance Growth And Governance

May 8, 2026 | finance.yahoo.com

Weave Communications, Inc. 2026 Q1 - Results - Earnings Call Presentation

May 4, 2026 | seekingalpha.com

Weave lifts 2026 guidance after Q1 beat; NexPoint adds investment capacity

May 1, 2026 | msn.com

Weave (WEAV) Q1 2026 Earnings Call Transcript

May 1, 2026 | finance.yahoo.com

Weave Communications Inc (WEAV) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ...

May 1, 2026 | finance.yahoo.com

Weave forecasts $275M-$278M 2026 revenue while expanding omnichannel AI Receptionist availability in Q2

April 30, 2026 | seekingalpha.com

Weave raises 2026 outlook as AWS faces Gulf outage

April 30, 2026 | msn.com

AI, biotech, and space sectors report May 1 milestones

April 30, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT, MDRX, SOPH, and WEAV Company Descriptions

Health Catalyst NASDAQ:HCAT

$2.28 +0.07 (+3.17%)

Closing price 04:00 PM Eastern

Extended Trading

$2.28 0.00 (-0.22%)

As of 07:34 PM Eastern

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Veradigm NASDAQ:MDRX

$4.80 0.00 (0.00%)

As of 01:46 PM Eastern

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

SOPHiA GENETICS NASDAQ:SOPH

$6.84 +1.15 (+20.21%)

Closing price 04:00 PM Eastern

Extended Trading

$7.24 +0.40 (+5.77%)

As of 07:50 PM Eastern

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Weave Communications NYSE:WEAV

$6.86 +0.11 (+1.61%)

Closing price 03:59 PM Eastern

Extended Trading

$6.86 +0.01 (+0.09%)

As of 07:56 PM Eastern

Weave Communications, Inc. provides a customer experience and payments software platform in the United States and Canada. Its platform enables small and medium-sized healthcare businesses to maximize the value of their patient interactions and minimize the time and effort spent on manual or mundane tasks. The company's products include Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manages heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging to communicate with patients; Missed Call Text to take action in real time upon notification of a missed call; Missed Text Auto-Reply; Team Chat, a group messaging solution that helps practitioners and their staff communicate with each other from their work stations; and Weave Mobile App; It also offers Weave Reviews and Respond Assistant to request, collect, monitor, and respond to reviews; Weave Email Marketing and Email Assistant; Text Connect to interact with their existing and potential patients online directly through their websites; Weave Payments, a payment processing solution; Practice Analytics provides real-time data on patient retention, appointment scheduling, treatment acceptance rates, and revenue generation; and Call Intelligence. In addition, the company provides Digital Forms to collect patient information; Insurance Verification that provides patient insurance plan details; and Scheduling to send automatic scheduling reminders through text message. It serves customers in dental, optometry, veterinary, medical, plastic surgery, physical therapy, medical spa, and other medical specialty industries. The company was formerly known as Recall Solutions, LLC and changed its name to Weave Communications, Inc. in October 2015. Weave Communications, Inc. was founded in 2008 and is headquartered in Lehi, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HCAT, MDRX, SOPH, and WEAV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HCAT, MDRX, SOPH, and WEAV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HCAT, MDRX, SOPH, and WEAV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT, MDRX, SOPH, and WEAV Company Descriptions

Health Catalyst NASDAQ:HCAT

Veradigm NASDAQ:MDRX

SOPHiA GENETICS NASDAQ:SOPH

Weave Communications NYSE:WEAV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HCAT, MDRX, SOPH, and WEAV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HCAT, MDRX, SOPH, and WEAV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HCAT, MDRX, SOPH, and WEAV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCAT, MDRX, SOPH, and WEAV Company Descriptions

Health Catalyst NASDAQ:HCAT

Veradigm NASDAQ:MDRX

SOPHiA GENETICS NASDAQ:SOPH

Weave Communications NYSE:WEAV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools